Last update 23 Aug 2025

BIBW-2948

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
BIBW 2948, BIBW-2948-BS, BIBW2948 BS
Target
Action
antagonists
Mechanism
EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists)
Active Indication-
Originator Organization
Active Organization-
Inactive Organization
License Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Obstructive bronchitisPhase 2
United States
01 Aug 2008
Obstructive bronchitisPhase 2
France
01 Aug 2008
Obstructive bronchitisPhase 2
Germany
01 Aug 2008
Bronchitis, ChronicPhase 2
United States
17 Jan 2007
Bronchitis, ChronicPhase 2
Germany
17 Jan 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
48
Placebo
(Placebo Total)
pyjtvtkmly(yirludomvi) = kahzhypoux dfyiozqtvh (nmnzocydxj, 1.836)
-
19 Nov 2021
(BIBW2948 Total)
pyjtvtkmly(yirludomvi) = rbjaezpcat dfyiozqtvh (nmnzocydxj, 1.676)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free